These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16959487)

  • 21. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
    Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
    J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity.
    Long YO; Higuchi RI; Caferro TR; Lau TL; Wu M; Cummings ML; Martinborough EA; Marschke KB; Chang WY; López FJ; Karanewsky DS; Zhi L
    Bioorg Med Chem Lett; 2008 May; 18(9):2967-71. PubMed ID: 18400499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.
    Li JJ; Sutton JC; Nirschl A; Zou Y; Wang H; Sun C; Pi Z; Johnson R; Krystek SR; Seethala R; Golla R; Sleph PG; Beehler BC; Grover GJ; Fura A; Vyas VP; Li CY; Gougoutas JZ; Galella MA; Zahler R; Ostrowski J; Hamann LG
    J Med Chem; 2007 Jun; 50(13):3015-25. PubMed ID: 17552509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands.
    Van Dort ME; Jung YW
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1045-7. PubMed ID: 11327585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QSAR Analysis of a Series of Hydantoin-based Androgen Receptor Modulators and Corresponding Binding Affinities.
    Wang X; Han W; Li J
    Mol Inform; 2019 Aug; 38(8-9):e1800147. PubMed ID: 30969473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators.
    Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Jan; 17(2):439-43. PubMed ID: 17079140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.
    Schlienger N; Lund BW; Pawlas J; Badalassi F; Bertozzi F; Lewinsky R; Fejzic A; Thygesen MB; Tabatabaei A; Bradley SR; Gardell LR; Piu F; Olsson R
    J Med Chem; 2009 Nov; 52(22):7186-91. PubMed ID: 19856921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.
    Higuchi RI; Arienti KL; López FJ; Mani NS; Mais DE; Caferro TR; Long YO; Jones TK; Edwards JP; Zhi L; Schrader WT; Negro-Vilar A; Marschke KB
    J Med Chem; 2007 May; 50(10):2486-96. PubMed ID: 17439112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
    Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
    J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold.
    Sun C; Robl JA; Wang TC; Huang Y; Kuhns JE; Lupisella JA; Beehler BC; Golla R; Sleph PG; Seethala R; Fura A; Krystek SR; An Y; Malley MF; Sack JS; Salvati ME; Grover GJ; Ostrowski J; Hamann LG
    J Med Chem; 2006 Dec; 49(26):7596-9. PubMed ID: 17181141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
    van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic and binding activities of 5 alpha-reductase and androgen receptors in hamster prostate.
    Cabeza M; Bratoeff E; Heuze I; Ramírez E; Sánchez M; Flores E
    Proc West Pharmacol Soc; 2003; 46():128-31. PubMed ID: 14699908
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors.
    Schneider J; Kneip C; Jahnel U
    Pharmacology; 2009; 84(2):74-81. PubMed ID: 19590256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production.
    Mitchell L; Wang Z; Hu LY; Kostlan C; Carroll M; Dettling D; Du D; Pocalyko D; Wade K
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1310-3. PubMed ID: 19201190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the three SARMs RAD-140, GLPG0492 and GSK-2881078 in two different in vitro bioassays, and in an in silico androgen receptor binding assay.
    Zierau O; Kolodziejczyk A; Vollmer G; Machalz D; Wolber G; Thieme D; Keiler AM
    J Steroid Biochem Mol Biol; 2019 May; 189():81-86. PubMed ID: 30825507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties.
    Cook CE; Kepler JA
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1213-6. PubMed ID: 15686944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
    Martinborough E; Shen Y; Oeveren Av; Long YO; Lau TL; Marschke KB; Chang WY; López FJ; Vajda EG; Rix PJ; Viveros OH; Negro-Vilar A; Zhi L
    J Med Chem; 2007 Oct; 50(21):5049-52. PubMed ID: 17887661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and structure-activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).
    Rowbottom MW; Vickers TD; Tamiya J; Zhang M; Dyck B; Grey J; Schwarz D; Heise CE; Hedrick M; Wen J; Tang H; Wang H; Fisher A; Aparicio A; Saunders J; Goodfellow VS
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2171-8. PubMed ID: 17350839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
    Omwancha J; Brown TR
    Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationship studies for hydantoins and analogues as voltage-gated sodium channel ligands.
    Zha C; Brown GB; Brouillette WJ
    J Med Chem; 2004 Dec; 47(26):6519-28. PubMed ID: 15588087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.